PD-0332334

DRUG2 trials

Sponsors

Pfizer

Conditions

Generalized Anxiety DisorderPharmacokineticsRenal Dialysis

Phase 1

A Single Dose Study Investigating The Elimination Of PD-0332334 In Patients Receiving Regular Hemodialysis

CompletedNCT00730145

PfizerPharmacokinetics, Renal Dialysis

Start: 2008-09-30End: 2009-01-31Updated: 2010-02-17

Phase 3

6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)

WithdrawnNCT00738738

PfizerGeneralized Anxiety Disorder

Start: 2009-01-31End: 2009-02-28Updated: 2012-12-03